Aleksandr L Urakov¹*, Natalya A Urakova², Anastasia P Stolyarenko³, Darya O Suntsova³, Ilnur I Yagudin³, Nikita M Muhutdinov³ and Varvara V Sokolova³

¹DM, Professor, Head of the Department of General and Clinical Pharmacology, Izhevsk State Medical Academy, Izhevsk, Russia
²PhD, Associate Professor of the Department of Obstetrics and Gynecology, Izhevsk State Medical Academy, Izhevsk, Russia
³Student of Izhevsk State Medical Academy, Izhevsk, Russia

*Corresponding Author: Aleksandr L Urakov, DM, Professor, Head of the Department of General and Clinical Pharmacology, Izhevsk State Medical Academy, Izhevsk, Russia.

Received: November 14, 2022; Published: November 21, 2022

HIV continues to be a serious global public health problem, with 40.1 million [33.6-48.6 million] deaths to date [1]. Yet according to the World Health Organization (WHO), there is no cure for HIV. By all accounts, sexual contact with an infected partner is the most likely cause of infection [2-4]. A woman can acquire HIV from her sexual partner through blood, semen or vaginal secretions [4,5].

References

1. World Health Organization. “HIV/AIDS”. (2022).
2. Kapustin DV., et al. “New aspects of the etiology and pathogenesis of HIV infection (literature review)”. Journal of Siberian Medical Sciences 1 (2021): 92-104.
3. Wang Z., et al. “Trace the history of HIV and predict its future through genetic sequences”. Tropical Medicine and Infectious Disease8 (2022): 190.
4. Vardavas R and Blower S. “The emergence of HIV transmitted resistance in Botswana: "when will the WHO detection threshold be exceeded?". PLoS One1 (2007): e152.
5. Peterman TA., et al. “Risk of human immunodeficiency virus transmission from heterosexual adults with transfusion-associated infections”. JAMA 1 (1988): 55-58.
6. Suligoi B., et al. “The epidemic of HIV infection and AIDS, promotion of testing, and innovative strategies”. Annali dell'Istituto Superiore di Sanita1 (2010): 15-23.
7. Kawana R., et al. “Inactivation of human viruses by povidone-iodine in comparison with other antiseptics”. Dermatology (Basel, Switzerland) 195 (1997): 29-35.
8. Frank S., et al. “Povidone-iodine use in sinonasal and oral cavities: A review of safety in the COVID-19 era”. Ear, Nose, Throat Journal9 (2020): 586-593.
9. Urakov AL and Shabanov PD. “Acute respiratory syndrome-2 (SARS-CoV-2): A solution of hydrogen peroxide and sodium bicarbonate as an expectorant for recanalization of the respiratory tract and blood oxygenation in respiratory obstruction (review)”. Reviews on Clinical Pharmacology and Drug Therapy 4 (2021): 383-393.
10. Urakov АL and Urakova NA. “COVID-19: intrapulmonary injection of hydrogen peroxide solution eliminates hypoxia and normalizes respiratory biomechanics”. Russian Journal of Biomechanics4 (2021): 350-356.
11. Fisher E., et al. “COVID-19: intrapulmonary alkaline hydrogen peroxide can immediately increase blood oxygenation”. MEDICINSKI ČASOPIS 4 (2021): 135-138.
12. Abdool Karim Q., et al. “Preventing HIV infection in women: a global health imperative”. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 50 (2010): S122-S129.
13. GBD 2019 Tuberculosis Collaborators. “Global, regional, and national sex differences in the global burden of tuberculosis by HIV status, 1990-2019: results from the Global Burden of Disease Study 2019”. The Lancet Infectious Diseases2 (2022): 222-241.
14. Lan CW., et al. “Alcohol and sexual risk reduction interventions among people living in Russia: a systematic review and meta-analysis”. AIDS and Behavior10 (2014): 1835-1846.
15. Guinan ME and Leviton L. “Prevention of HIV infection in women: overcoming barriers”. Journal of the American Medical Women's Association.19723-4 (1995): 74-77.
16. Naziri H., et al. “Antiretroviral drug resistance mutations in naïve and experienced patients in Shiraz, Iran, 2014”. Archives of Virology9 (2016): 2503-2509.
17. Liu Z., et al. “Insights into the mechanism of drug resistance: X-ray structure analysis of multi-drug resistant HIV-1 protease ritonavir complex”. Biochemical and Biophysical Research Communications 2 (2013): 232-238.
18. Kampf G. “Efficacy of biocidal agents and disinfectants against the monkeypox virus and other orthopoxviruses”. The Journal of Hospital Infection 127 (2022): 101-110.
19. Fadaei A. “Viral Inactivation with Emphasis on SARS-CoV-2 Using Physical and Chemical Disinfectants”. The Scientific World Journal (2021): 9342748.
20. Kampf G., et al. “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents”. The Journal of Hospital Infection3 (2020): 246-251.
21. Urakov A., et al. “Post-injection complications. Nicolau syndrome as a consequence of local irritant effects of drugs, including antiseptics, local anesthetics, NSAIDs, steroids and anticoagulants”. Journal of Pharmaceutical Research International 33A (2022): 26-36.
22. Urakov AL. “Nikolau syndrome: Necrotic activity of drugs and ways to prevent post-injection abscesses (In memory of Professor László A Gömze)”. Creative Surgery and Oncology2 (2022): 159-163.
23. Katzung B and Trevor A. “Basic and Clinical Pharmacology”. 15^th (2020).
24. Bodduluri VP., et al. “Physico-chemical properties of antiseptics in surgery: What is not taken into account in treating long-term non-healing wounds”. Creative Surgery and Oncology3 (2021): 256-259.
25. Ravel J., et al. “Vaginal microbiome of reproductive-age women”. Proceedings of the National Academy of Sciences of the United States of America1 (2011): 4680-4687.
26. Ng K., et al. “In vivo oxygen, temperature and pH dynamics in the female reproductive tract and their importance in human conception: a systematic review”. Human Reproduction Update1 (2018): 15-34.
27. O'Hanlon DE., et al. “Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota”. PloS One11 (2013): e80074.
28. O'Hanlon DE., et al. “Vaginal pH measured in vivo: lactobacilli determine pH and lactic acid concentration”. BMC Microbiology 1 (2019): 13.
29. Boskey ER., et al. “Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source”. Human Reproduction (Oxford, England) 9 (2001): 1809-1813.
30. Lykke MR., et al. “Vaginal, cervical and uterine pH in women with normal and abnormal vaginal microbiota”. Pathogens (Basel, Switzerland) 2 (2021): 90.

Citation

Citation: Aleksandr L Urakov., et al. “AIDS and Sexual Transmission of HIV: Vaginal Liquid with a pH of 2.8-4.2 Protects Women's Health as a Natural Antiseptic". Acta Scientific Women's Health 4.12 (2022): 35-39.

Copyright

Copyright: © 2022 Aleksandr L Urakov., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.